glp-1 drug updates Compounded" drugs | Health Communication Research Laboratory GLP-1 Clinical Practice Updates: December

Clinical trials have provided limited insight into the long-term effects, as the longest trials spanned less than six years in adults and about one year in adolescents

Effectiveness and safety of the combination of sodium-glucose transport protein 2 inhibitors and glucagon-like peptide-1 receptor agonists in patients with type 2 diabetes mellitus: a systematic review and meta-analysis of observational studies

In a 40-week double blinded, placebo-controlled study, weekly injections of Tirzepatide (15mg) in Type 2 Diabetes Mellitus (T2DM) patients was capable of reducing body weight by an average of 10.1%, over placebo at 40 weeks

How should we approach patients on GLP-1 agonists

The lab where Goodman worked at Massachusetts General Hospital was one of the top places applying them to the study of hormones, and its leader, Joel Habener, had amassed serious funding to go after as many as possible

No missing data were imputed